Gandhinagar

MSc. in any branch of biological sciences from any reputed university, institute. Should be qualified any national level examination

Ph.D. in Biotechnology, Biological Sciences, Bioinformatics, Microbiology, Environmental Biotechnology, Life Sciences, Molecular Biology or equivalent degree.

HPLC, GC, IC method development, feasibility, verification, equivalency, validation for API, complex OSD products, oncology products, topical products having exposure to regulated, Semi Regulated & India markets

HPLC, GC, IC method development, Validation and Transfer for API, complex OSD, complex generics products like long acting injectables, nasal sprays, peptide injections, peptide OSDs, oncology and Topical products etc using various analytical technique. Expertly in peptide characterization. Well versed with USP/EP/BP/IP and various current regulatory guidelines ICH/ EMEA/ FDA Hands on experience on Nitrosamine and Genotoxic impurities method development, M.Pharm / M.Sc

Possess a post-graduate degree with first class in the appropriate branch of specialization in Pharmacy, as may be specified by the Government, the educational qualification shall have been obtained from any of the Universities established or incorporated by or under the Central or State Act in India, or any other educational institution recognized as such or deemed as a University under section 3 of the University Grants Commission Act, 1956 or possess an equivalent qualification recognized as such by the Government

To monitor the Demo, Scale up, exhibit, and launch batches. To take scale up batch, Exhibit batches and work on Trouble shooting. To perform investigation for Deviation/ OOS/ OOT observed at plant.

M.Sc. M.Pharma. M.V.Sc. from a recognised University. Institute. 4 years of experience of research, teaching in Central State Govt. Organisations, University or Research Institution or Central. State autonomous or other recognised institute of repute; The application must be filled in online mode and the hard copy of duly filled online applications forms with required annexure must reach to NIPER-A

Deciphering the cellular heterogeneity in unstable atherosclerotic plaques using single cell RNA sequencing and spatial whole transcriptomics for developing RNA based prognostic markers; Candidates with prior research experience in human clinical samples, scRNA techniques are encouraged to apply. MSc in Biotechnology/Life Science